Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024

SELL
$0.1 - $0.75 $95 - $712
-950 Closed
0 $0
Q1 2022

Aug 14, 2024

BUY
$2.13 - $3.85 $2,023 - $3,657
950 New
950 $2.2 Million
Q2 2021

Aug 30, 2024

BUY
$4.68 - $7.39 $4,446 - $7,020
950 New
950 $4.45 Million
Q2 2020

Aug 30, 2024

BUY
$3.07 - $4.68 $2,916 - $4,446
950 New
950 $3.26 Million
Q1 2020

Aug 30, 2024

SELL
$2.28 - $6.6 $18,240 - $52,800
-8,000 Closed
0 $0
Q4 2019

Aug 30, 2024

SELL
$3.34 - $5.51 $243 - $402
-73 Reduced 0.9%
8,000 $37.5 Million
Q2 2019

Aug 30, 2024

BUY
$3.59 - $8.37 $28,720 - $66,960
8,000 Added 10958.9%
8,073 $33.3 Million
Q4 2018

Aug 30, 2024

BUY
$7.3 - $18.3 $532 - $1,335
73 New
73 $533,000
Q2 2018

Aug 30, 2024

SELL
$5.43 - $9.83 $151,638 - $274,512
-27,926 Reduced 99.74%
73 $688,000
Q1 2018

Aug 30, 2024

SELL
$5.79 - $8.86 $96,913 - $148,298
-16,738 Reduced 37.41%
27,999 $166 Million
Q4 2017

Aug 30, 2024

SELL
$5.88 - $9.09 $549,462 - $849,424
-93,446 Reduced 67.62%
44,737 $346 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-15,511 Reduced 10.09%
138,183 $1.54 Billion
Q1 2017

Aug 30, 2024

BUY
N/A
153,694
153,694 $1.72 Billion

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.